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Abstract
Mammalian oocytes undergo an asymmetrical first meiotic division, extruding half of their chromosomes in a small polar
body to preserve maternal resources for embryonic development. To divide asymmetrically, mammalian oocytes relocate
chromosomes from the center of the cell to the cortex, but little is known about the underlying mechanisms. Here, we show
that upon the elevation of intracellular cAMP level, mouse oocytes produced two daughter cells with similar sizes. This
symmetrical cell division could be rescued by the inhibition of PKA, a cAMP-dependent protein kinase. Live cell imaging
revealed that a symmetrically localized cleavage furrow resulted in symmetrical cell division. Detailed analyses
demonstrated that symmetrically localized cleavage furrows were caused by the inappropriate central positioning of
chromosome clusters at anaphase onset, indicating that chromosome cluster migration was impaired. Notably, high
intracellular cAMP reduced myosin II activity, and the microinjection of phospho-myosin II antibody into the oocytes
impeded chromosome migration and promoted symmetrical cell division. Our results support the hypothesis that cAMP
plays a role in regulating asymmetrical cell division by modulating myosin II activity during mouse oocyte meiosis I,
providing a novel insight into the regulation of female gamete formation in mammals.
Citation: Chen D, Zhang Y, Yi Q, Huang Y, Hou H, et al. (2012) Regulation of Asymmetrical Cytokinesis by cAMP during Meiosis I in Mouse Oocytes. PLoS ONE 7(1):
e29735. doi:10.1371/journal.pone.0029735
Editor: Ferdinando Di Cunto, University of Turin, Italy
Received June 29, 2011; Accepted December 4, 2011; Published January 11, 2012
Copyright:  2012 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Basic Research Program (2011CB944501, 2007CB947401) of China (973), and the Knowledge Innovation
Program of the Chinese Academy of Sciences (KSCX2-EW-R-07). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: qshi@ustc.edu.cn
Introduction
Asymmetrical cell division generates unequally sized daughter
cells that are destined to acquire different fates. This plays
important roles in multiple biological processes [1,2,3,4,5,6]. In
female mammals, after an exquisite process of homologous
chromosome pairing and synapsis, immature oocytes are blocked
at prophase I of meiosis with a morphologically visible nucleus,
called the germinal vesicle (GV). As the oocyte resumes meiosis in
response to hormonal stimulation, it undergoes a process of
meiotic maturation to complete meiosis I with an extreme form of
asymmetrical cell division. This produces the secondary oocyte
and the much smaller first polar body [7,8,9,10]. The secondary
oocyte is arrested at metaphase II until fertilization or partheno-
genetic activation drives meiotic spindle II to rotate 90 degrees to
facilitate the extrusion of the second polar body [11]. During both
meiosis I and II, cortical migration and asymmetrical positioning
of the meiotic spindle is crucial for the asymmetry of the division
[10,12].
During the meiotic maturation process in mouse oocytes, the
meiotic spindle assembles around the site where germinal vesicle
breakdown (GVBD) takes place. After assembly, the spindle
migrates towards the nearest site on the cortex before anaphase
onset [13]. During mitosis, the spindle also migrates to the
appropriate location before the initiation of anaphase. Dynamic
astral microtubules and cytoplasmic dynein, a minus-end-directed
motor protein whose asymmetrical activation and localization is
regulated by cortical polarity factors, are proposed to play
prominent role in mitotic spindle migration [14]. However, astral
microtubules cannot play a similar role in directing metaphase I
spindle migration in mammalian oocytes because oocytes lack
conventional centrosomes and do not exhibit prominent astral
microtubules on spindle poles [15]. In fact, several studies have
demonstrated that actin is involved in this spindle migration; for
example, the metaphase I spindle remains centrally positioned in
oocytes treated with actin polymerization inhibitors [12,16,17] or
in oocytes lacking the actin nucleator formin-2 [17,18,19]. It has
also been demonstrated that activated myosin helps to propel the
microtubule spindle to the cortex by pulling on the cytoplasmic
actin network that extends from the spindle poles to the cortex
[19,20,21,22,23,24]. These recent studies suggested that myosin
pulling on an actin filament network is important for spindle
positioning and anchoring to the cortex in mammalian oocytes.
When chromosomes come close to the cortex after spindle
migration, they induce cortical differentiation and restrict the
position of the cleavage furrow, which is generated by the
enrichment of actin filaments and the reduction of microvilli
[8,9,25]. Furrow ingression is initiated shortly after the formation
of cleavage furrow. Notably, the pulling force of myosin on the
contractile ring is essential for furrow ingression [22,26,27,28].
Therefore, both of the two critical events of meiotic maturation,
spindle migration and furrow ingression, are associated with
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mouse oocytes during meiotic maturation.
cAMP, a cyclic nucleotide, plays a key role in regulating female
gamete maturation in mammals and some invertebrates [29,30].
Specifically, meiotic resumption of oocytes is triggered by a
decrease in intracellular cAMP levels [31,32,33]. The spontaneous
meiotic resumption of denuded oocytes can be reversibly pre-
vented by incubation with membrane-permeable cAMP analogs,
cAMP phosphodiesterase (PDE) inhibitors or adenylate cyclase
activators, such as dibutyryl cAMP (dbcAMP), 3-isobutyl-1-
methylxanthine (IBMX) and forskolin [34,35]. For example, it
has been shown that intracellular cAMP in oocytes decreases
within 2 hours of the removal of IBMX, and that this decrease
promotes the commitment to resuming meiosis I [36,37]. Because
of the roles cAMP plays in meiotic arrest, cAMP analogs, PDE
inhibitors and adenylate cyclase activators are widely employed to
sustain high intracellular cAMP levels in order to inhibit GVBD in
oocyte cultures in vitro. However, it remains unclear whether
cAMP plays other roles in the meiotic maturation process of
mouse oocytes.
In this study, intracellular cAMP was elevated in mouse oocytes
using the chemicals mentioned above (i.e., IBMX, dbcAMP and
forskolin) to explore the possible roles of cAMP during meiotic
maturation. A large proportion of these chemically treated oocytes
underwent symmetrical cell divisions and generated two daughter
oocytes with similar sizes. Detailed analyses showed that chro-
mosomes were located in the center of the cell, resulting in a
symmetrical cleavage furrow, and thus, symmetrical cell division.
Live cell imaging revealed that the migration of the chromosome
cluster towards the cortex was significantly suppressed in treated
oocytes. Notably, the activity of myosin II (a cAMP-PKA pathway
downstream molecule) was impaired in the oocytes with elevated
cAMP. Oocytes that had been microinjected with an antibody
against activated myosin II also mimicked the severely impaired
chromosome migration and symmetrical division caused by
elevated cAMP levels. These data provide evidence that cAMP
plays a role in regulating chromosome migration by modulating
the activity of myosin II, affecting the localization of the cleavage
furrow, and thus, asymmetrical cell division in meiosis I.
Results
Elevated intracellular cAMP gives rise to abnormal
cytokinesis in mouse oocytes
IBMX and dbcAMP have been widely used in in vitro culture
of oocytes to inhibit GVBD by maintaining high levels of
intracellular cAMP [38,39,40,41,42]. In the present study, oocytes
were treated for 24 hours with 0.2 mM IBMX or 0.3 mM
dbcAMP. As shown in Figure 1 and movie S1, 83.4562.28% of
oocytes in the control group completed meiosis I by producing a
large secondary oocyte and a tiny first polar body (‘‘1Pb’’ type);
10.5163.56% remained at the germinal vesicle (GV)-stage (‘‘GV’’
type); and 6.0461.36% underwent germinal vesicle breakdown
(GVBD) but did not produce daughter cells (‘‘1-cell’’ type). No
oocytes in the control group produced two daughter cells of similar
sizes (‘‘2-cell’’ type) (Fig. 1A). However, in oocytes treated with
IBMX or dbcAMP, the percentages of ‘‘1Pb’’ type decreased
significantly (37.7067.22% in IBMX and 36.5868.46% in
dbcAMP groups). The percentage of ‘‘GV’’ type oocytes changed
only slightly (4.7661.63% in IBMX and 17.2067.89% in
dbcAMP groups). Notably, the proportion of ‘‘1-cell’’ type oocytes
(31.1964.52% in IBMX and 29.1363.84% in dbcAMP
groups) and ‘‘2-cell’’ type oocytes (27.8661.49% in IBMX and
Figure 1. Incubation with dbcAMP or IBMX disrupts asymmet-
ric division in meiosis I in mouse oocytes. Denuded mouse
oocytes were cultured in DMSO control medium for 16 hours (control
group), or in M16 medium containing 0.3 mM dbcAMP or 0.2 mM IBMX
for 24 hours, followed by 16 hours of culture in M16 medium (dbcAMP
and IBMX group). (A) Representative images of different oocyte
phenotypes after incubation. GV designates oocytes remaining in the
GV stage; 1Pb designates mature eggs that extruded a first polar body
in the first meiotic division; 1-cell designates oocytes that displayed
only one cell; 2-cell designates oocytes that produced two daughter
cells of similar sizes in the first meiotic division. Arrowheads are used to
indicate 2-cell oocytes. Scale Bar: 100 mm. (B) Comparison of cell
division types between oocytes treated with or without IBMX or
dbcAMP. Data are the mean 6 SEM from 3 independent experiments. P
values were calculated with a 264 x2-test. N: number of cells analyzed.
doi:10.1371/journal.pone.0029735.g001
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treated groups (Fig. 1A).
The frequency of ‘‘2-cell’’ type oocytes increased in a time-
dependent manner after dbcAMP or IBMX treatment (Fig. S1A).
To rule out the possibility that these cytokinetic disorders were
secondary to delayed GVBD, we performed a set of drug treat-
ment experiments on post-GVBD oocytes. To further confirm that
the abnormal cytokinetic results were directly caused by cAMP
and its downstream factors, we treated post-GVBD oocytes with a
adenylate cyclase activator, forskolin [43,44,45], and a PKA
inhibitor, H-89 [46,47], to determine their effects on cytokinesis.
As shown in Figure 2, all three cAMP-elevating chemicals
promoted both the ‘‘2-cell’’ and ‘‘1-cell’’ type division patterns.
We also found that H-89 could rescue the symmetrical division
Figure 2. High intracellular cAMP disrupts asymmetric division in post-GVBD oocytes, and H-89 rescues this effect on asymmetric
division. Denuded mouse oocytes at the GV stage were collected and cultured in M16 medium for 90 min. Then, oocytes that had undergone GVBD
were transferred into DMSO control medium or medium supplemented with different drugs and cultured for 16 hours. (A) Representative images of
oocytes after a 16 hour incubation. Arrowheads indicate 2-cell oocytes. Scale bar: 100 mm. (B) Oocyte division results after 16 hours incubation. Data
are the mean 6SEM from 3 independent experiments. ** P,0.01, 263 x2-test, compared to concurrent control.
doi:10.1371/journal.pone.0029735.g002
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of ‘‘1-cell’’ type divisions (Fig. 2B). IBMX/dbcAMP treatment of
post-GVBD oocytes also increased the frequencies of both ‘‘2-cell’’
and ‘‘1-cell’’ divisions in a dose-dependent manner (Figs. S1B–C).
Altogether, these observations indicate that high intracellular
cAMP perturbs the asymmetrical division of primary oocytes.
Altered cleavage furrow positioning and ingression
perturb the asymmetrical division of primary oocytes
To investigate how increased intracellular cAMP perturbs the
asymmetrical division of primary oocytes, we carried out time-
lapse imaging experiments on post-GVBD oocytes receiving
0.6 mM dbcAMP or1.0 mM IBMX treatment to track the process
of meiosis I, with special attention to the localization of the
cleavage furrow. To quantitatively describe the localization of the
cleavage furrow, the vertical distance from the far-end cortex to
the cleavage furrow was measured in both daughter cells, and the
ratio of the longer distance over the shorter distance (DL/DS) was
used as a measure of furrow localization (Fig. 3). For those oocytes
formed more than one furrow (Movie S5), we measured the
relevant data of the furrows that regressed later than the others.
For the 55 control oocytes examined, the average ratio was
3.0860.13 with a maximum value of 5.34 and a minimum value
of 1.68. Based on these data, cleavage furrow localization was
defined ‘‘abnormal’’ if the DL/DS ratio was less than 1.68.
According to the DL/DS ratios, 44% and 40.4% of dbcAMP- and
IBMX-treated oocytes displayed abnormally positioned cleavage
furrows. Notably, all ‘‘2-cell’’ type divisions (10/50 in dbcAMP
and 7/52 in IBMX groups) were attributed to the ingression of a
centrally localized cleavage furrow (DL/DS ,1.1, Fig. 3B, Movie
S2). Similar results were obtained in oocytes that had been treated
with lower concentrations of the two chemicals (0.3 mM dbcAMP,
0.2 mM IBMX) at the GV stage (Fig. S2). Treatment of post-
GVBD oocytes with lower chemical concentrations also produced
abnormally localized cleavage furrows— over 10% oocytes
displayed more symmetrically localized cleavage furrow (Fig. S3),
indicating that cAMP drugs at the relatively lower concentration
can also affect the normal division. Taken together, these results
demonstrate that dbcAMP and IBMX cause cleavage furrows to
position centrally, leading to symmetrical oocyte divisions and the
subsequent production of ‘‘2-cell’’ type oocytes.
As shown in Figure 3C–D and Movies S3, S4, the ‘‘1-cell’’ type
division was caused by cleavage furrow regression. Treatment of
oocytes with dbcAMP or IBMX significantly increased the
frequency of furrow regression (22% and 17.3% in the dbcAMP
IBMX groups, compared to 7.5% of controls). Notably, the
regression took place at similar frequencies in oocytes with
normally and abnormally localized cleavage furrows (Fig. 3E, Fig.
S3B). Interestingly, we also observed two oocytes, one from the
dbcAMP group and the other from IBMX group, that formed two
simultaneous cleavage furrows; in these oocytes, the two furrows
both regressed sequentially (Movie S5). Taken together, our data
indicate that dbcAMP and IBMX treatments increased the
likelihood of cleavage furrow regression.
To investigate possible causes of furrow regression, we
monitored chromosome movements in both control and treated
groups. Frequencies of lagging chromosomes in treated groups
were slightly higher than in the control group (Figure 3E), but the
differences were not statistically significant (data not shown). In
both control and treated groups, lagging chromosomes occurred
more frequently in anaphase/telophase than in prometaphase
(Figure 3E). No furrow regression was observed when chromo-
somes lagged only at prometaphse (Figure 3E); besides, over 75%
of furrow regression were concomitant with anaphase/telophase
chromosome lagging (3/4, 8/11 and 9/9 in control, dbcAMP and
IBMX group) (Figure 3C–E, Movies S3, S4, S5), indicating that
lagging chromosomes at anaphase/telophase contributes to furrow
regression. Interestingly, in the control group, most oocytes with
anaphase/telophase lagging chromosomes were able to complete
cytokinesis, while in treated groups, about half of the oocytes with
anaphase/telophase lagging chromosomes underwent furrow
regression (9/19 in dbcAMP group and 9/17 in IBMX group)
(Figure 3E). These results indicate that the treatement of cAMP
elevating drugs increased the incidence of the lagging-chromo-
some-related furrow regression.
Abnormal cleavage furrow positioning is associated with
mislocalized chromosome clusters at anaphase onset
Previous studies have highlighted the important role of the
chromosome cluster (or meiotic spindle) during polar body
formation [8,9,12,48]. Chromosome cluster migration toward
the cortex induces cortical differentiation, and thus restricts
cleavage furrow position. Cortical differentiation is characterized
by actin filament (F-actin) enrichment and microvilli reduction on
the cortex [8,9,25,48]. To test whether cortical differentiation was
affected by high levels of intracellular cAMP, the F-actin
distribution was investigated at the initiation of anaphase or
cytokinesis by staining with TRITC-conjugated phalloidin. At the
onset of anaphase I, ‘‘F-actin caps’’ were observed in 53.33% and
61.90% of oocytes receiving IBMX and dbcAMP treatment,
respectively, but in 82.60% of controls (Fig. 4A). No F-actin cap
was observed in oocytes with more centrally located chromosomes,
either in the control or treated groups (Fig. 4A, row 2). At the
beginning of cytokinesis, an F-actin cap remained visible in all 15
control oocytes, but in only 4/18 IBMX-treated oocytes and 2/11
dbcAMP-treated oocytes. No ‘‘F-actin cap’’ was observed in cells
that divided symmetrically after treatment (Fig. 4B). These results
not only confirmed that cortical differentiation depends on the
location of the chromosome cluster but also indicates that
intracellular cAMP may affect chromosome cluster positioning
in oocytes.
Because cortical differentiation is dependent on the localization
of chromosome clusters and restricts the position of the cleavage
furrow, it is possible that mislocalization of the cleavage furrow
could be caused by abnormal chromosome position in oocytes. To
test this hypothesis, we investigated the relationship between
chromosome cluster positioning and furrow localization using live
cell imaging. To quantify the localization of the chromosome
cluster, the shortest distance between the chromosome cluster and
the cortex was measured at movie initiation (D0) and anaphase
onset (DA), and the DA/D0 ratio was used as a measurement of
chromosome position at anaphase onset. In the 55 control oocytes,
DA/D0 averaged 0.4660.01 with a maximum of 0.70 and a
minimum of 0.27. Based on the range of DA/D0 ratios from the
control group, we defined chromosome cluster positioning as
‘‘abnormal’’ if the DA/D0 ratio was greater than 0.70. Abnormally
localized chromosome clusters were observed in 44% and 40.4%
of oocytes treated with dbcAMP and IBMX, respectively (Fig. 3E).
The average ratio of DA/D0 was significantly greater in the treated
oocytes (0.8360.04 in dbcAMP and 0.7960.05 in IBMX groups)
than in the controls (0.5660.03) (Fig. 5C). Notably, all cells with
abnormally localized cleavage furrows displayed abnormal
chromosome cluster positioning at anaphase onset, and no
centrally localized cleavage furrows were observed in oocytes with
normally positioned chromosome clusters (Fig. 3E). Therefore, our
data demonstrate that the formation of abnormally localized
cleavage furrows is dependent on the abnormal positioning of
chromosome clusters at anaphase onset in mouse oocytes.
A Novel Role of cAMP in Oocyte Meiosis I
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29735Figure 3. IBMX and dbcAMP treatment perturbed oocyte cytokinesis. Denuded mouse oocytes at the GV stage were collected and cultured
in M16 medium for 90 min. Then, oocytes that had undergone GVBD were transferred into DMSO control medium or medium supplemented with
0.6 mM dbcAMP or 1.0 mM IBMX for subsequent live cell imaging. Representative live cell images were collected from oocytes undergoing normal
cytokinesis with furrow abscission (A), symmetric cytokinesis with furrow abscission (B), asymmetric cytokinesis with furrow regression (C) and
symmetric cytokinesis with furrow regression (D). White arrowheads: prometaphase lagging chromosome. Yellow arrowheads: anaphase/telophase
lagging chromosome. The DL and DS in (A), (B), (C) and (D) represent the vertical distances from the far-end cortex to the cleavage furrow in the larger
and smaller daughter cells, respectively. Time points (hours:minutes) indicate the time elapsed from the beginning of imaging. Chromosomes were
stained with Hoechst 33342, shown in red. Corresponding movies are provided in the supplemental materials. (E) Analysis of cell division in the
control, dbcAMP and IBMX group, with each row representing a single oocyte division. Colour indicates whether the cell showed the presence (red)
A Novel Role of cAMP in Oocyte Meiosis I
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positioned chromosome cluster at anaphase onset
To investigate how the abnormal positioning of chromosomes
occurred, we utilized live cell imaging techniques to monitor the
movement of chromosome clusters during meiosis I. To quantify
the movement of the chromosome cluster, the shortest distance
from chromosome cluster to the cortex was measured at movie
initiation (D0) and every hour thereafter (Dt) until the oocytes
examined initiated anaphase (Fig. 5B). The ratio Dt/D0 was used
as a parameter for chromosome cluster localization, and the
change of the Dt/D0 was used as an indicator of the movement of
chromosome clusters during prometaphase I. In the control group,
Dt/D0 began to decrease at 3 hours after movie initiation and
continued to decrease until anaphase onset, when the chromosome
clusters were observed to be adjacent to the cortex (Fig. 5A). In
contrast, Dt/D0 did not change significantly in either IBMX- or
dbcAMP-treated oocytes during the first 8 hours after the
beginning of imaging (Fig. 5B), and the chromosome clusters
remained almost completely still (Fig. 3C, 3D and 5A). At the
initiation of anaphase, DA/D0 was significantly greater in the
treated oocytes (0.8360.04 in dbcAMP and 0.7960.05 in IBMX)
than in the controls (0.5660.03) (Fig. 5C). The suppression of
chromosome migration was also observed in oocytes that had been
treated with lower concentrations of the two chemicals (0.3 mM
dbcAMP, 0.2 mM IBMX) at the GV stage (Fig. S4) Thus, these
data indicate that the abnormal localization of chromosomes at
anaphase onset can be attributed to the impaired cortex-ward
migration of the chromosome cluster.
Decreased myosin II activity impedes chromosome
cluster migration in oocytes
It has been reported that activated myosin II is a downstream
effector of the cAMP-PKA pathway [49,50,51] and plays
important roles in the regulation of spindle migration and
asymmetrical division in meiosis I [19,20,21,22,23,24]. Because
myosin II is activated by the phosphorylation of its regulatory light
chain (MLC) at Ser19/Thr18 [52], we carried out immunostain-
ing of phospho(Ser19)-myosin II to detect myosin II activity in
control, IBMX-treated and dbcAMP-treated oocytes. The results
showed that all control oocytes (20/20) displayed strong staining
for phosphorylated MLC around the chromosome cluster,
whereas only 61.5% (24/39) and 58.8% (10/17) of IBMX- and
dbcAMP-treated oocytes did so (Fig. 6A), indicating that myosin II
activity around the chromosomes was reduced in IBMX- and
dbcAMP-treated oocytes. Immunoblotting against phospho(-
Ser19)-myosin II presented further evidence that treatment with
dbcAMP or IBMX decreased myosin II activity in mouse oocytes
(Fig. 6B).
To determine whether decreased myosin activity could affect
the asymmetry of cytokinesis, we microinjected phospho-MLC II
(Ser19) antibodies into oocytes to inhibit myosin activity. The
results showed that 7.1762.98% of anti-phospho-MLC microin-
jected oocytes underwent 2-cell type divisions, whereas no 2-cell
divisions were observed in control oocytes that were microinjected
with donkey anti-mouse IgG (Figs. 7A and B). We also used live
cell imaging to follow chromosome movement in these oocytes. In
control oocytes, chromosomes migrated towards the cortex
beginning shortly after GVBD. In contrast, chromosomes
remained centrally located in the anti-phospho-MLC microinject-
ed oocytes (Fig. 7C). Similarly, treatment with blebbistatin, an
inhibitor of myosin II [53], generated symmetrical divisions in 17
out of 43 oocytes (Fig. S5). Therefore, the reduced myosin activity
in oocytes impaired chromosome migration and thus contributed
to the symmetrical cytokinesis of meiosis I.
Discussion
This study showed that the administration of chemicals that
elevate intracellular cAMP caused some oocytes to undergo
symmetrical cell division during meiosis I, thus producing two
daughter cells with similar sizes. This symmetrical cell division
could be rescued by inhibiting PKA, a cAMP-dependent protein
kinase. Detailed analyses showed that the impaired migration
of chromosome clusters led to the symmetrical localization of
or absence (green) of abnormal anaphase chromosome localization (A.C.L., first column) or abnormal cleavage furrow localization (A.F.L., second
column); occurrence of cleavage furrow regression (red) or not (green) (C.F.R., third column); presence (red) or absence (green) of lagging
chromosomes at prometaphase (P, fourth column) or anaphase/telophase (A/T, fifth column). The proportion of red in each column is included
below. Chromosome localization was deemed ‘‘abnormal’’ if the ratio of the shortest chromosome-cortex distance at anaphase initiation (DA) over
that at movie initiation (DO) was greater than 0.68 (DA/D0 .0.68). Furrow localization was deemed ‘‘abnormal’’ if DL/DS was less than 1.70 (DL/DS
,1.70).
doi:10.1371/journal.pone.0029735.g003
Figure 4. Cortical specification in the primary oocyte is
dependent on chromosome cluster position. Representative
images of oocytes before cytokinesis initiation (A) and after cytokinesis
completion (B). Denuded oocytes were incubated in the presence of
0.3 mM dbcAMP or 0.2 mM IBMX for 24 hours, followed by incubation
in M16 for 9 hours, or in control medium in the absence of dbcAMP or
IBMX for 10 hours, and subsequently fixed and co-stained with
Alexa594-phalloidin (red) and Hoechst 33342 (blue). Oocytes with
(row 1 in panel A) or without (row 2 in panel A) an ‘‘F-actin cap’’ were
observed in both the control group and treatment groups. Arrowheads
indicate ‘‘F-actin cap’’ localization. Scale bar: 20 mm.
doi:10.1371/journal.pone.0029735.g004
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of myosin II, downstream of the cAMP-PKA pathway, was
decreased when intracellular cAMP was elevated and microinjec-
tion of oocytes with antibodies against activated myosin II severely
impeded chromosome migration toward the cortex during meiosis
I and resulted in symmetrical divisions. These results provide
evidence that cAMP plays a role in modulating chromosome
migration by regulating myosin II activity, subsequently affecting
cleavage furrow localization and the asymmetrical division of
meiosis I in oocytes.
An interesting and novel discovery in this study is that oocytes
with elevated intracellular cAMP do not position the meiotic
spindle adjacent to the cortex, which is required to form a polar
body. During the maturation process in these oocytes, the centrally
formed metaphase I spindle failed to translocate to the cortex,
remaining in the center of the oocyte until anaphase onset (Fig. 5,
Movie S2). During mitosis, the spindle needs to migrate to the
appropriate location before anaphase initiation, a process that is
proposed to rely on dynamic astral microtubules and the minus-
end-directed MT motor protein dynein [14]. However, astral
Figure 5. IBMX and dbcAMP treatment of post-GVBD oocytes disturbed chromosome migration. Denuded GV stage oocytes were first
cultured in M16 medium for 90 min; after GVBD, the oocytes were transferred into DMSO control medium or medium supplemented with 0.6 mM
dbcAMP or 1.0 mM IBMX for live cell imaging. Chromosome movement was tracked during meiosis I. (A) Representative time-lapse images of
chromosome movement from imaging initiation to anaphase onset. Time from imaging initiation is shown (hours:minutes). Red: DNA. (B) Green dots
indicate the position of the chromosome cluster. The shortest distance between the chromosomes and the cortex was measured at each time point
(Dt) and divided by the distance to the cortex at the beginning of the experiment (D0). Dt/D0 was used as an indicator of chromosome movement
and plotted against time. Panel (C) shows the relative position of the chromosome cluster at anaphase onset, as DA/D0.D A is the shortest distance
between the chromosomes and the cortex at anaphase initiation. ** P,0.01, Student’s t-test, compared to concurrent control. N: number of cells
analyzed.
doi:10.1371/journal.pone.0029735.g005
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metaphase I spindle migration in mammalian oocytes, due to the
lack of conventional centrosomes and prominent astral microtu-
bules on spindle poles [15]. Studies of the actin cytoskeleton have
demonstrated that actin is involved in spindle positioning during
meiosis I; the metaphase I spindle remains centrally positioned in
oocytes that have been treated with actin polymerization inhibitors
[12,16,17] or lack the actin polymerization activator formin-2
[17,18,19]. However, the actin cytoskeleton appeared normal in
oocytes with elevated cAMP, in that all treated oocytes initiated
furrow formation (Fig. 3, Fig. S2, Fig. S3), which is known to be
driven by the actomyosin-based contractile ring [54], though not
all oocytes accomplished abscission of the cleavage furrow (Fig. 3,
Fig. S2, Fig. S3). Clearly, increased cAMP did not grossly distort
the actin cytoskeleton, although asymmetrical spindle positioning
did not occur.
A recent study by Schuh and Ellenberg [24] suggests that
myosin pulling on actin contributes to the motion of the meiotic
spindle. They propose that activated myosin helps to propel the
microtubule spindle to the cortex by pulling on the cytoplasmic
actin network that extends from the spindle poles to the cortex.
Their model, which has been experimentally verified, predicts that
spindles will move end-on to the nearest cortex and that motion
will speed up as the spindle nears the cortex. Consistent with this
role for myosin, we observed activated, phosphorylated myosin
light chain protein concentrated adjacent to the meiotic spindle in
untreated oocytes (Fig. 6A). Additionally, microinjection of
phospho-myosin II antibody into oocytes reduced the rate of
chromosome migration and promoted symmetrical cell division
(Fig. 7). Similarly, we observed decreased myosin activity in
oocytes with elevated cAMP (Fig. 6). Our study confirms the
important role of myosin for spindle positioning and anchoring to
the cortex in mammalian oocytes.
In meiosis I mouse oocytes, when chromosomes come close to
the cortex after spindle migration during meiosis I, they induce
cortical differentiation which restricts the position of the cleavage
furrow; this differentiation is reflected by enrichment of actin
filaments and reduction of microvilli [8,9,10,25,55]. Consistently,
our results of F-actin immunostaining demonstrated that cortical
differentiation occurred when the chromosomes approached the
oocyte cortex (Fig. 4). It is also worth noting that no F-actin cap
was observed in oocytes with more centrally positioned chromo-
somes. Live cell imaging analysis revealed that all oocytes were
able to initiate cleavage furrow formation, regardless of whether
chromosomes were centrally or cortically positioned (Fig. 3, Fig.
S2, Fig. S3). This suggests that cortical differentiation has a
positive, but nonessential, role in furrow formation. Our obser-
vations are inconsistent with the proposal that furrow induction by
the spindle midzone in the oocyte is distance-dependent, as
suggested by Wang et al. [56]. In that study, centrally formed
spindle midzones induced neither membrane furrow nor cytoki-
nesis, while subcortical spindle midzones induced cortical
furrowing and polar body extrusion after egg activation [56].
This inconsistency suggests a probable difference in the mecha-
nisms regulating furrow formation in meiosis I and meiosis II in
mammalian oocytes.
Most of the furrow regression incidents, which were more
frequent in treated oocytes than in control oocytes, were con-
comitant with anaphase/telophase lagging chromosome (Figs. 1B
and 3C–E). One mechanism that could explain this finding is the
Figure 6. IBMX and dbcAMP treatment decreased myosin II activity in mouse oocytes. (A) Immunostaining of control (CTRL) oocytes
cultured in control medium for 10 hours and oocytes cultured in M16 medium for 10 hours after a 20 hour incubation with 0.3 mM dbcAMP or
0.2 mM IBMX. Oocytes were stained with anti-phospho-MLC2 (Ser19) antibody (myosin II, green) and Hoechst 33342 (DNA, blue). (B) The myosin II
activities of control or treated oocytes were assayed. Extracts from control, dbcAMP-treated and IBMX-treated oocytes were immunoblotted with
antibodies against phospho-MLC2 or b actin. Each lane represents a protein sample derived from 300 oocytes.
doi:10.1371/journal.pone.0029735.g006
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reported to interfere with the completion of cytokinesis [57,58].
Another interesting discovery is that oocytes with anaphase/
telophase lagging chromosomes in treated groups displayed much
higher rates of cleavage furrow regression than those oocytes in
control group (Figure 3E). Given that the myosin activity was
reduced in treated oocytes (Fig. 6) and the pulling force of myosin
on the contractile ring is essential for cytokinesis completion
[22,26,27,28,59], it is reasonable to suggest that the higher rates of
furrow regression in treated oocytes are attributable to the reduced
myosin II activity. Besides, it seems that furrow regression and
furrow localization are independent (Fig. 3, Fig. S2, Fig. S3),which
is consistent with previous studies [60].
The chemicals used in this study elevate intracellular cAMP by
acting as a cAMP mimic (dbcAMP) [61], by preventing the PDE-
dependent degradation of cAMP (IBMX) [62], or by over-
activating adenylyl cyclase (forskolin). The PKA inhibitor H-89
was able to inhibit the symmetrical division induced by high
intracellular cAMP (Fig. 2), indicating that cAMP regulates
asymmetrical division during oocyte meiosis I by activating
cAMP-dependent PKA. This is inconsistent with work by Wang
et al. in Xenopus, which suggested that PKA activity is restrictive
only up to GVBD [63]. The later stages of oocyte maturation,
including formation of the metaphase I spindle, homolog
separation (anaphase), emission of the first polar body and
formation of metaphase II spindle, are not sensitive to PKA
activation [63]. One likely explanation is the species difference —
the cAMP-PKA regulation pathway may not be identical in
rodents and Xenopus, and mice may thus be more susceptible to
cAMP-induced PKA activation. Newhall et al. proposed in 2006
that type II PKA translocated from the cytosol [64,65,66] to
mitochondria to ensure GVBD initiation [67]. Given that the
knockout mice used by Newhall et al. were not completely infertile
[67], and that soluble (cytosolic) type I PKA is present in rodent
oocytes [68], we speculate that the cAMP may have activated type
I PKA in the post-GVBD oocytes in our study. Increased PKA
activity could attenuate RhoA activation and thus reduce Rho-
kinase activity, which is responsible for myosin II regulatory light
chain activation [69,70,71]. Additionally, activated PKA phos-
phorylates MLCK (Myosin Light Chain Kinase), thereby reducing
its activity and leading to decreased myosin activity [72].
Consistent with these theories, we observed reduced myosin
activity in drug treated oocytes (Fig. 6). Additionally, specifically
suppressed myosin activity in oocytes significantly reduced the
chromosome migration rate (Fig. 7). This suggests that as a
downstream effector of cAMP-PKA pathway, myosin II is
responsible for chromosome migration defects and subsequent
abnormalities in cytokinesis, indicating that the cAMP-PKA
pathway might be involved in the regulation of asymmetrical
chromosome positioning.
In summary, this study indicates that the cAMP-PKA pathway
contributes to the regulation of chromosome subcortical location
and cytokinesis in mouse oocyte meiosis I. The regulatory role of
the cAMP-PKA pathway in chromosome migration and cleavage
furrow ingression may be exerted through myosin II. This is the
first time that the cAMP-PKA pathway has been reported to
regulate not only meiosis resumption but also other meiotic events
in mouse oocytes. Moreover, it has recently been proposed that
reduced non-muscle myosin activity could cause cytokinesis failure
and multipolar mitosis in cultured somatic cells [22]. Therefore,
the mitotic and meiotic side effects of chemicals that are widely
used to activate the cAMP-PKA pathway for therapeutic or
agricultural purposes should be considered carefully prior to their
use.
Materials and Methods
ICR female mice aged 3–6 weeks were purchased from the
National Rodent Laboratory Animal Center (Shanghai Branch,
China). The collection and using of mice oocytes were under the
approval of the Institutional Review Board at University of
Science and Technology of China, the approval ID: UST-
CAU201000004.
Figure 7. Microinjection of oocytes with monoclonal anti-
phospho-myosin antibody facilitated abnormal cytokinesis in
meiosis I. (A) Representative images of oocytes taken 16 hours after
microinjection with DAM-488 2
nd antibody (Control) and anti-phospho-
MLC2 (Ser19) antibody (P-myosin). The arrowhead indicates a
symmetrically dividing oocyte. Scale bar: 100 mm. (B) The frequency
of 1 Pb, GV, 1-cell and 2-cell type divisions in the Control and P-myosin
groups. The P value was calculated using a 264 x2-test. (C) The shortest
distance between chromosomes and the cortex was measured in 15
oocytes per group at GVBD (DGV) and hourly time points after GVBD
(Dt). Dt/DGV plotted against time was used as an indicator of
chromosome movement.
doi:10.1371/journal.pone.0029735.g007
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All chemicals used in this study were purchased from Sigma
Chemical Company (St. Louis, MO, USA) unless otherwise noted.
Stock solutions of IBMX (0.5 M), forskolin (10 mM) and H-89
(10 mg/ml) were dissolved in dimethyl sulfoxide (DMSO), stock
solution of dbcAMP (30 mM) were dissolved in distilled water. All
the stock solutions were stored at 220uC and diluted with culture
medium prior to use. In the cases of treatment on GV-stage
oocytes, the control group employed M16 medium with cor-
respondent DMSO concentration. In the cases of treatment on
post-GVBD oocytes, the DMSO concentration of the control
medium was at the highest level used in the different experimental
treatments.
Collection and culturing of denuded oocytes
Mice were sacrificed by cervical dislocation. Cumulus-oocyte
complex (COC) were released from antral follicles by puncturation
in M2 medium (Sigma-Aldrich, Cat. No. M7167). After being
pipetted repeatedly, cumulus cells were removed from COC. Only
denuded oocytes showing clear nuclear membrane (GV oocytes)
were collected. Oocytes were washed 3 times in M2 medium then
transferred into M16 medium (Sigma-Aldrich, Cat. No. M7292).
Oocytes were cultured in M16 medium covered by mineral oil
(Sigma-Aldrich, Cat. No. M8410), in a humidified atmosphere of
5% CO2 at 37uC. For post-GVBD treatment, oocytes were first
cultured in M16 medium for 90 min, then the oocytes which had
underwent GVBD were transferred into M16 medium with
IBMX/dbcAMP/forskolin/H-89 for following experiments. Be-
fore use, all the media were pre-equilibrated in an incubator with
5% CO2 and 100% humidity at 37uC.
Microinjection of denuded oocytes
Monoclonal antibody of phospho-myosin II light chain (Cell
Signaling Techonology, Cat. No. 3675) or donkey anti-mouse
antibody conjugated with Alexa Fluor 488 (Molecular Probes, Cat.
No. A21202) was diluted at 1:500 and microinjected into the
cytoplasm of GV oocytes with an Eppendorf TransferMan NK2
microinjector and borosilicate glass capillaries (World Orecision
Instruments, Cat. No. TW100F-6). The oocytes were maintained
in M2 medium during microinjection, then were cultured in M16
medium in a humidified atmosphere with 5% CO2 at 37uC.
Immunostaining
For phospho-myosin II staining, the oocytes were fixed with
3.7% paraformaldehyde in PBS for 1 hour at 30uC, and then
rinsed 3 times in blocking solution (1% BSA in PBS) followed by
permeabilization with 0.25% Triton X-100 in PBS for 10 minutes
at room temperature. Then, rabbit antibody against Ser19-
phospho myosin II light chain-2 (Cell Signaling Technology,
Cat. No. 3671) was applied at 1:100 for 1 hour at room
temperature. An Alexa Fluor 488 dye conjugated anti-rabbit
antibody (Molecular Probes, Cat. No. A21206) was used at 1:150
as the secondary antibody. Before the incubation in PBS
containing 5 mg/ml Hoechst 33342 for 10 minutes, oocytes were
rinsed 3 times in blocking solution (10 minutes each) to reduce
nonspecific binding. For F-actin staining, the oocytes were fixed
for 25 minutes in 4% paraformaldehyde in PBS, and then
permeabilized in PBS containing 0.1% Triton X-100 and 0.3%
BSA for 10 minutes. After the incubation for 2 hours in PBS
containing 0.01% Triton X-100, 0.03% BSA, and 5 U/ml
TRITC-phalloidin at room temperature (Sigma-Aldrich, Cat.
No. P1951), the oocytes were rinsed 3 times in PBS containing
0.01% Triton X-100 and 0.03% BSA, followed by an incubation
in PBS containing 5 mg/ml Hoechst 33342 for 10 minutes before
observation.
Immunoblotting analysis
Control oocytes were collected for lysates at 10 hours after
GVBD, so were those which had been incubated with dbcAMP or
IBMX for 20 hours. Western blotting was performed as previously
described [73]. Lysates were separated by SDS-PAGE and the
proteins were then transferred to nitrocellulose membranes
(Amersham Biosciences, Cat. No. RPR303D). The membranes
were then blocked in TBST (0.5% Tween-20 in TBS) containing
5% BSA for 1 hours, incubated with a rabbit anti-Ser19-phospho
myosin II light chain-2 antibody (Cell Signaling Technology, Cat.
No. 3671; 1:1000) or a mouse anti-beta actin antibody (Abcam,
Cat. No. Ab52; 1:1000) overnight at 4uC. Alkaline phosphatase
(AP)-conjugated anti-mouse IgG (Promega, Cat. No. S372B;
1:1000) or anti-rabbit IgG (Promega, Cat. No. S373B; 1:1000)
were used as secondary detection reagents. Phosphorylated myosin
II light chain-2 and beta-actin protein levels were evaluated by the
detection of activity of alkaline phosphatase using a Lumi-Phos kit
(Pierce Biotechnology, KJ1243353).
Live cell imaging and analysis
For live cell imaging, oocytes were collected and placed in M16
medium supplemented with 5 ng/ml Hoechst 33342 (Molecular
Probes) and chemicals in correspondent concentration on gridded
coverglass bottom dishes (MatTek, CatNo. P35G-1.5-7-C-grid).
The dishes were placed in a 16 cm610.8 cm61.8 cm chamber
with humidified 5% CO2 delivered into it. The chamber was
housed in a custom-made 37uC incubator attached with a
microscope.
Images at multiple locations on the coverglass were automat-
ically acquired using a Nikon TE2000E inverted microscope
equipped with a 206Nikon Plan Apo objective, a linearly-encoded
stage (Proscan, Prior), a Hamamatsu Orca-ER CCD camera and
NIS-Elements AR v3.0 software. Fluorescence illumination was
provided by a mercury-arc lamp with two neutral density filters
(for a total 128-fold reduction in intensity). Fluorescence and
differential interference contrast images were acquired every
15 minutes. The oocytes that entered mitosis at least 10 hours
before the end of imaging were analyzed for chromosome cluster
dynamics. Only the oocytes that entered anaphase with clearly
visible chromosome clusters and cleavage furrows were analyzed
for anaphase chromosome-cortex distance and furrow positioning.
Statistics
The number of oocytes used for each experiment is indicated in
the figure legends. Unless otherwise specified, data were collected
from three independently replicated experiments and presented as
the mean 6 SEM. Statistical significance was assessed by means of
two-tailed Student’s t-test or 264 chi-square test. In all cases,
P,0.05 was deemed significant.
Supporting Information
Figure S1 Disturbance of meiosis I induced by dbcAMP
and IBMX is time- and dose-dependent. (A) Denuded
mouse oocytes were cultured in M16 medium containing 0.3 mM
dbcAMP or 0.2 mM IBMX for different lengths of time. The
frequency of ‘‘2-cell’’ divisions (oocytes produced two daughter
cells of similar sizes) increased with increased duration of dbcAMP
or IBMX treatment. (B) and (C) The frequency of 2-cell and 1-cell
divisions increased with increasing concentration of IBMX or
dbcAMP. Denuded mouse oocytes were cultured in M16 medium
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different concentrations of IBMX or dbcAMP for 15 hours. Data
represent the mean 6 SEM from 3 independent experiments.
(TIF)
Figure S2 IBMX and dbcAMP treatment perturb oo-
cytes cytokinesis. Denuded mouse oocytes at the GV stage
were cultured in M16 medium supplemented with 0.3 mM
dbcAMP or 0.2 mM IBMX for 20 hours, then transferred into
drug-free medium for live cell imaging. Control oocytes were
collected and cultured in DMSO control medium. Representative
live cell images were collected from oocytes undergoing normal
cytokinesis with furrow abscission (A), symmetric cytokinesis with
furrow abscission (B), asymmetric cytokinesis with furrow
regression (C) and symmetric cytokinesis with furrow regression
(D). The DL and DS in (A), (B), (C) and (D) represent the vertical
distances from the far-end cortex to the cleavage furrow in larger
and smaller daughter cells, respectively. Time is shown as
hours:minutes after GVBD. Chromosomes were stained with
Hoechst 33342 (red). Panel (E) summarizes the normal and
abnormal cytokinesis in control, dbcAMP-treated and IBMX-
treated groups, with each row representing a single oocyte
division. The cell divisions are indicated in different colors:
presence (red) or absence (green) of abnormal anaphase chromo-
some localization (A.C.L., first column) or abnormal cleavage
furrow localization (A.F.L., second column); occurrence of
cleavage furrow regression (red) or not (green) (C.F.R., third
column). The proportion of red in each column is included below.
Chromosome localization was deemed ‘‘abnormal’’ if the ratio of
the shortest chromosome-cortex distance at anaphase initiation
(DA) to that at GVBD (DGV) was greater than 0.6 (DA/DGV .0.6).
Furrow localization was deemed ‘‘abnormal’’ if DL/DS was less
than 1.9 (DL/DS ,1.9).
(TIF)
Figure S3 Incubation with 0.2 mM IBMX or 0.3 mM
dbcAMP did not significantly affect post-GVBD oocytes.
Denuded mouse oocytes at the GV stage were collected and
cultured in M16 medium for 90 min; then, oocytes that had
undergone GVBD were transferred into DMSO control medium
or medium supplemented with 0.3 mM dbcAMP or 0.2 mM
IBMX for live-cell imaging. Shown is a summary of normal and
abnormal cytokinesis in control, dbcAMP and IBMX groups, with
each row representing a single oocyte division. The cell divisions
are indicated in different colors: presence (red) or absence (green)
of abnormal anaphase chromosome localization (A.C.L., first
column) or abnormal cleavage furrow localization (A.F.L., second
column); occurrence of cleavage furrow regression (red) or not
(green) (C.F.R., third column). The proportion of red in each
column is included below. Chromosome localization was deemed
‘‘abnormal’’ when DA/DO .0.68. The vertical distances from the
far-end cortex to the cleavage furrow in larger and smaller
daughter cells were measured in each oocyte, and furrow
localization was deemed ‘‘abnormal’’ if DL/DS ,1.70.
(TIF)
Figure S4 IBMX and dbcAMP treatment on oocytes at
GV stage disturbed chromosome migration. Chromosome
movement was tracked by live cell imaging in control oocytes, and
the oocytes treated for 20 hours with 0.2 mM IBMX or 0.3 mM
dbcAMP. (A) Representative time lapse images of chromosome
movement from GVBD to anaphase onset. The time of GVBD
was set as 00:00 (hours:minutes). Red: DNA. (B) Green dots
indicate the position of the chromosome cluster. The shortest
distance between the chromosomes and the cortex was measured
at each time point (Dt) and divided by the distance to the cortex at
GVBD (DGV). Dt/DGV plotted against time was used as an
indicator of chromosome movement. Panel (C) shows the relative
position of the chromosome cluster (i.e., average DA/DGV)a t
anaphase onset. DA is the shortest distance between the
chromosomes and the cortex at anaphase initiation. P values are
from a t-test.
(TIF)
Figure S5 Blebbistatin induces symmetric meiosis I
division in mouse oocytes. (A) Oocytes were incubated with
(Bleb) or without (CTRL) 0.2 mM blebbistatin for 16 hours.
Arrowheads indicate oocytes that produced 2 daughter cells of
similar size (‘‘2-cells’’). (B) The frequency of 2-cells was elevated by
the presence of 0.2 mM blebbistatin.
(TIF)
Movie S1 A representative time-lapse movie showing a
mouse oocyte that completes normal meiosis I. Acquisi-
tion time is shown as hours: minutes: seconds in the upper left
corner.
(AVI)
Movie S2 A representative time-lapse movie showing a
mouse oocyte that completes symmetric cytokinesis.
Acquisition time is shown as hours: minutes: seconds in the upper
left corner.
(AVI)
Movie S3 A representative time-lapse movie showing a
mouse oocyte with asymmetrically positioned cleavage
furrow that undergoes furrow regression eventually.
Acquisition time is shown as hours: minutes: seconds in the upper
left corner.
(AVI)
Movie S4 A representative time-lapse movie showing a
mouse oocyte with symmetrically positioned cleavage
furrow that undergoes furrow regression eventually.
Acquisition time is shown as hours: minutes: seconds in the upper
left corner.
(AVI)
Movie S5 A representative time-lapse movie showing a
mouse oocyte with two simultaneous formed cleavage
furrows that regressed sequentially. Acquisition time is
shown as hours: minutes: seconds in the upper left corner.
(AVI)
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